What Should You Do With Danaher Stock At $250 After Q1 Beat?

Danaher stock (NYSE: DHR), a conglomerate with products in life sciences, biotechnology, and diagnostics fields, recently posted its Q1 results that exceeded the stree...

Related Keywords

,Life Sciences ,Health Care ,Trefis High Quality Portfolio ,Danaher Valuation Ratios Comparison ,Dhr ,Danaher ,S Ampp 500 ,Dhr Stock ,Dhr Revenue ,Dhr Q1 ,Dhr Valuation ,